Chlorpheniramine, Phenylpropanolamine

Contac Cold Extra Strength Capsules

12 MG + 75 MG Capsule (Sustained-Release)CanadaCancelledAuthorised 10 Jun 1997

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Cold Capsule IVUnited States · 12MG; 75MG · capsule, extended release · Graham DMSame form
Cold Capsule VUnited States · 8MG; 75MG · capsule, extended release · Graham DMSame form
ContilenBrazil · Germed Farmaceutica LtdaSame substance
Triaminic-12United States · 12MG; 75MG · tablet, extended release · NovartisSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Chlorpheniramine, Phenylpropanolamine

Contac Cold Extra Strength Capsules

12 MG + 75 MG Capsule (Sustained-Release)CanadaCancelledAuthorised 10 Jun 1997

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entry

Health Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Chlorpheniramine, Phenylpropanolamine
Strength: 12 MG + 75 MG
Dosage form: Capsule (Sustained-Release)
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 10 Jun 1997
Registration: DIN 02230425
Marketing authorisation holder: Smithkline Beecham Consumer Healthcare, Division of Smithkline Beecham INC.
ATC code: R01BA51
Group: Respiratory system
Supply: NON-PRESCRIPTION DRUGS

Cancelled

Contact C SRCChlorpheniramine + Phenylpropanolamine · 8 MG + 75 MG · Capsule (Sustained-Release)CanadaCancelled

Coricidin D Long Acting TabChlorpheniramine + Phenylpropanolamine · 8 MG + 50 MG · Tablet (Extended-Release)CanadaCancelled

Corsym SuspensionChlorpheniramine + Phenylpropanolamine · 4 MG / 5 ML + 37.5 MG / 5 ML · SuspensionCanadaCancelled

Extra Strength Contac C - SRCChlorpheniramine + Phenylpropanolamine · 12 MG + 75 MG · Capsule (Sustained-Release)CanadaCancelled

Ornade Af LiquidChlorpheniramine + Phenylpropanolamine · 2.5 MG / 5 ML + 15 MG / 5 ML · LiquidCanadaCancelled

Ornade Af Spansule SRCChlorpheniramine + Phenylpropanolamine · 12 MG / SRC + 75 MG / SRC · Capsule (Sustained-Release)CanadaCancelled

Ornade LiquidChlorpheniramine + Phenylpropanolamine · 1.5 MG / 5 ML + 15 MG / 5 ML · LiquidCanadaCancelled

Ornade Spansule SRCChlorpheniramine + Phenylpropanolamine · 8 MG / SRC + 75 MG / SRC · Capsule (Sustained-Release)CanadaCancelled

Triaminic Cold and Allergy SyrupChlorpheniramine + Phenylpropanolamine · 2 MG / 5 ML + 12.5 MG / 5 ML · SyrupCanadaCancelled